Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models-Reference-Cited by-同舟云学术

Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models

Published:2011-10-12 Issue:12 Volume:10 Page:2350-2362
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Cheong Jae-Ho,Park Eun Sung,Liang Jiyong,Dennison Jennifer B.,Tsavachidou Dimitra,Nguyen-Charles Catherine,Wa Cheng Kwai,Hall Hassan,Zhang Dong,Lu Yiling,Ravoori Murali,Kundra Vikas,Ajani Jaffer,Lee Ju-Seog,Ki Hong Waun,Mills Gordon B.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma;Cell Metabolism;2024-08

2. Metabolic adaptations in cancer stem cells: A key to therapy resistance;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

3. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation;Anticancer Research;2024-04-27

4. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors;Cancer Cell International;2024-04-10

5. Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo;Biomedicine & Pharmacotherapy;2024-04